CARDINAL HEALTH INC
CAHCardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 11, 2026
6dMarket Overview
Stock performance and key metrics
1 upcoming, 1 past
CAH Earnings Report
EPS Est: $2.42 | FQ end 2026-06 | Call: 2026-08-11 15:00:00
How CAH's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tc99m tilmanocept | Phase 2 | Rhabdomyosarcoma | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in CARDINAL HEALTH INC's drug pipeline?→
CatalystAlert tracks 1 drug candidate in CARDINAL HEALTH INC's (CAH) pipeline across Phase 2. Its lead program is Tc99m tilmanocept (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CARDINAL HEALTH INC's next FDA catalyst?→
CARDINAL HEALTH INC's (CAH) next tracked catalyst is a Earnings expected August 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CAH biotech catalysts?→
Add CAH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CARDINAL HEALTH INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.